GLP-1 coverage in South Carolina
Medicaid no longer covers GLP-1s for obesity here. What that means, the indications that are still mandatory, and what it costs if you pay cash.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
South Carolina eliminated Medicaid coverage of GLP-1s for obesity treatment.
South Carolina was among the four states that ended coverage after October 2025. That leaves cash-pay or a non-obesity indication as the realistic routes for most Medicaid enrollees in the state. Everything below is sourced — we are not going to tell you what a South Carolina clinic charges, because every provider we track is 50-state telehealth and prices the same wherever you live. What actually differs by state is coverage, and that is what this page is about.
Why South Carolina is different
South Carolina sits in the South, the region with the second-highest adult obesity prevalence in the country at 34.5%. Ending coverage in a high-prevalence, lower-income state removes the option from a larger share of the population than the same decision would elsewhere, and cash-pay pricing does not adjust for local incomes.
Medicaid and GLP-1s in South Carolina
Coverage for obesity is optional for states — the national picture is on our coverage index. Here is where South Carolina sits.
| South Carolina | |
|---|---|
| Status | Medicaid no longer covers GLP-1s for obesity here |
| Region | South — regional adult obesity prevalence 34.5% |
| Board of pharmacy | South Carolina Board of Pharmacy |
If you are on Medicaid in South Carolina
What to do in South Carolina: Check whether you qualify under a mandatory indication, and if you are paying cash, compare against the Medicare programme if you are approaching eligibility — it starts in July 2026.
Coverage for type 2 diabetes, cardiovascular disease and sleep apnea is mandatory everywhere, so a refusal framed around weight loss is not the end of it — and on Medicare, the $50 programme starts 1 July 2026 regardless of which state you are in.
Paying cash in South Carolina
Providers are licensed across all 50 states and charge the same here as anywhere, so there is no local price to hunt for — the cheapest verified all-in rates are Ozari Health at $86 for semaglutide and Trimi at $125 for tirzepatide. Full tables in the cheapest tirzepatide. If you buy compounded, check the pharmacy licence with the South Carolina Board of Pharmacy, or with the board in whichever state that pharmacy actually operates from — frequently not South Carolina.
South Carolina: common questions
When did South Carolina drop coverage?
After October 2025. KFF's survey found 16 states covering GLP-1s for obesity as of that month; South Carolina was one of four that eliminated coverage in the period after, alongside California, New Hampshire and Pennsylvania.
Is cash-pay realistic in South Carolina?
The cheapest verified all-in rates are around $86 to $125 a month, which is a stretch on a Medicaid income. The mandatory indications and the July 2026 Medicare programme are the more realistic routes for most people affected by the change.
Sources: KFF, “Medicaid Coverage of and Spending on GLP-1s”, 16 January 2026; CDC Adult Obesity Prevalence Maps, 2024 data, published 3 December 2025. Verified 2026-09-18. Coverage positions change mid-year — confirm yours with your plan. Not medical, legal or benefits advice.
More from the desk
- Medicare, GLP-1s and the $50 month
CMS is running a time-limited programme giving eligible Part D members certain GLP-1s for $50 a month. If you are on Medicare, read this before paying cash for anything.
- The cheapest tirzepatide online
Every provider whose monthly price actually includes the medication, sorted on what you are billed in month two.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.